Company / Working Capital per Share
Charles River Laboratories Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$6.64
FY2025
5-year range
$4.84 / $10.87
FY2021-FY2025
Trend
-16.7%
vs FY2024
Sector context
#64 of 159
Health Care
What the data says
At $6.64, Charles River Laboratories's working capital per share ranks #64 of 159 in the Health Care sector. Working Capital per Share has fluctuated over the past 10 years, ranging from $4.84 in FY2021 to $10.87 in FY2023.
Based on SEC 10-K filings.
6.64 in FY2025 with a 5-year CAGR of -2.1%.
Declined from $10.87 to $6.64 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -1.2%
- 5-Year CAGR
- -2.1%
- 10-Year CAGR
- -
Sector benchmark
#64 of 159 in Health CareTop 40% of 159This company $6.64 Sector average $24.27
▼
-72.6% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 16.7% year-over-year.
- Ranks #64 out of 159 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2023.
- Lowest working capital per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.64 | -16.7% |
| FY2024 | $7.97 | -26.7% |
| FY2023 | $10.87 | +57.9% |
| FY2022 | $6.88 | +42.2% |
| FY2021 | $4.84 | -34.4% |
| FY2020 | $7.38 | +14.4% |
| FY2019 | $6.45 | -9.9% |
| FY2018 | $7.16 | -6.6% |
| FY2017 | $7.67 | +57.6% |
| FY2016 | $4.87 | -6.9% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026